On Nov. 11, 2005, the U.S. Congress authorized the 2-year extension of Postage Stamp for Breast Cancer Research…
On Nov. 10, 2005, Stanford researchers announced they had discovered obestatin, a hormone that suppresses appetite. The discovery…
On Nov. 7, 2005, the National Cancer Institute launched a cancer biorepository pilot project designed to standardize biospecimen…
On Oct. 30, 2005, the Bill & Melinda Gates Foundation announced three grants totaling $258.3 million for advanced…
On Oct. 18, 2005, the Arizona BioIndustry Association (AZBio) announced a three-year grant from the Flinn Foundation to…
On Oct. 17, 2005, the FDA approved lowering the age limit to 12 mos for the remaining U.S.-licensed…
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
On Oct. 7, 2005, a new Federal Medicare rule became effective that required all long-term care facilities to…
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
On Oct. 5, 2005, the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer,…
On Sept. 28, 2005, the National Cancer Institute and the National Institute of Neurological Disorders and Stroke (NINDS)…
On Sept. 26, 2005, San Diego business leader and philanthropist John J. Moores contributed $4 million to The…
On Sept. 22, 2005, the Siteman Cancer Center opened a new center at Barnes-Jewish St. Peters Hospital. The…
On Sept. 16, 2005, preliminary results from a large, clinical trial of digital vs. film mammography showed no…
On Sept. 12, 2005, David H. Murdock announced a $1.5 billion scientific and economic revitalization project called the…
On Sept. 6, 2005, the vaccine that combined the measles, mumps, rubella, and varicella antigens (Proquad by Merck)…
On Aug. 31, 2005, the inactivated, injectable influenza vaccine (Fluarix) by GlaxoSmithKline (GSK) was licensed. The vaccine was…
On Aug. 29, 2005, the U.S. Centers for Disease Control and Prevention (CDC) responded to the crises presented…
On Aug. 18, 2005, the Medically Fragile Children’s Program was established at the Medical University of South Carolina….
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
On Aug. 8, 2005, the Energy Policy Act ( P.L. 109-58 ) was passed by the U.S. Congress…
On Jul. 18, 2005, Oregon Health & Science University (OHSU) announced receipt of a five-year, $10 million award…
On Jul. 16, 2005, Virginia Mason Medical Center opened an expanded Center for Hyperbaric Medicine on Seattle’s First…
On Jul. 13, 2005, The Life Sciences Discovery Fund Authority (LSDF) was established and a total of $350…
On Jul. 12, 2005, Corixa Corp., based on First Hill in Seattle, was acquired by Glaxosmithkline (GSK) for…
On Jun. 29, 2005, the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 (P.L. 109-18) amended…
On Jun. 22, 2005, the Fred Hutchinson Business Alliance announced that the 2005 E. Donnall Thomas Medal of…
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) licensed a 2nd Tdap vaccine (Adacel by…
On Jun 8, 2005, Dr. Andras Nagy at Mount Sinai Hospital announced Canada’s first human embryonic stem cell…
On Jun. 8, 2005, the Oklahoma Medical Research Foundation’s Sir Alexander Fleming scholar program celebrated it’s 50th class…